Skip to content
Advancing Biomedical Sciences with ZATA

Advancing Biomedical Sciences with ZATA

Advancing Biomedical Sciences with ZATA

  • About
    • Company
    • Cofounders of ZATA
    • Team
    • Investors and partnership
    • Employment opportunity
  • Technology
    • Oligotherapeutics (ZONs)
    • Antipathogens
      • ZAP-Systems
      • ZCIs for Killed Vaccines
  • Pipeline
  • Contact
  • News
  • Home

September 25-29 2017

Dr. David Tabatadze, President and CEO of ZATA presented ZATA’s new generation oligonucleotides at the “Discovery on Target” meeting in Boston, MA on September 25-29, 2017 (http://www.discoveryontarget.com/Oligonucleotide-Therapeutics). The meeting addressed advances in genomics, gene editing, oligonucleotide synthesis, delivery and manufacturing.

September 5, 2017March 1, 2018

Post navigation

Previous Previous post: June 25-30, 2017
Next Next post: March 27th, 2018
  • Contact Us
  • Terms of Use
  • Privacy Policy
Create a website or blog at WordPress.com